scholarly journals Body image dissatisfaction in patients with inflammatory bowel disease: a systematic review

2019 ◽  
Vol 6 (1) ◽  
pp. e000255 ◽  
Author(s):  
Sophie Elizabeth Beese ◽  
Isobel Marion Harris ◽  
Janine Dretzke ◽  
David Moore
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Body Image ◽  
Narrative Analysis ◽  
Bowel Disease ◽  
Female Gender ◽  
Body Image Dissatisfaction ◽  
Inflammatory Bowel

Background and aimsLittle is known about the relationship between inflammatory bowel disease (IBD) and body image. The aim of this systematic review was to summarise the evidence on body image dissatisfaction in patients with IBD across four areas: (1) body image tools, (2) prevalence, (3) factors associated with body image dissatisfaction in IBD and (4) association between IBD and quality of life.MethodsTwo reviewers screened, selected, quality assessed and extracted data from studies in duplicate. EMBASE, MEDLINE, PsycINFO and Cochrane CENTRAL were searched to April 2018. Study design–specific critical appraisal tools were used to assess risk of bias. Narrative analysis was undertaken due to heterogeneity.ResultsFifty-seven studies using a body image tool were included; 31 for prevalence and 16 and 8 for associated factors and association with quality of life, respectively. Studies reported mainly mean or median scores. Evidence suggested female gender, age, fatigue, disease activity and steroid use were associated with increased body image dissatisfaction, which was also associated with decreased quality of life.ConclusionThis is the first systematic review on body image in patients with IBD. The evidence suggests that body image dissatisfaction can negatively impact patients, and certain factors are associated with increased body image dissatisfaction. Greater body image dissatisfaction was also associated with poorer quality of life. However, the methodological and reporting quality of studies was in some cases poor with considerable heterogeneity. Future IBD research should incorporate measurement of body image dissatisfaction using validated tools.

scholarly journals QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: importance of clinical, demographic and psychosocial factors

2014 ◽  
Vol 51 (3) ◽  
pp. 192-197 ◽  
Author(s):  
Joana MAGALHÃES ◽  
Francisca Dias de CASTRO ◽  
Pedro Boal CARVALHO ◽  
Maria João MOREIRA ◽  
José COTTER
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Disease ◽  
Social Relations ◽  
Bowel Disease ◽  
Multivariate Regression ◽  
Univariate Analysis ◽  
Female Gender ◽  
Categorical Variables ◽  
Inflammatory Bowel

Context Inflammatory bowel disease causes physical and psychosocial consequences that can affect the health related quality of life. Objectives To analyze the relationship between clinical and sociodemographic factors and quality of life in inflammatory bowel disease patients. Methods Ninety two patients with Crohn’s disease and 58 with ulcerative colitis, filled in the inflammatory bowel disease questionnaire (IBDQ-32) and a questionnaire to collect sociodemographic and clinical data. The association between categorical variables and IBDQ-32 scores was determined using Student t test. Factors statistically significant in the univariate analysis were included in a multivariate regression model. Results IBDQ-32 scores were significantly lower in female patients (P<0.001), patients with an individual perception of a lower co-workers support (P<0.001) and career fulfillment (P<0.001), patients requiring psychological support (P = 0.010) and pharmacological treatment for anxiety or depression (P = 0.002). A multivariate regression analysis identified as predictors of impaired HRQOL the female gender (P<0.001) and the perception of a lower co-workers support (P = 0.025) and career fulfillment (P = 0.001). Conclusions The decrease in HRQQL was significantly related with female gender and personal perception of disease impact in success and social relations. These factors deserve a special attention, so timely measures can be implemented to improve the quality of life of patients.

scholarly journals Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses—Part I

2018 ◽  
Vol 24 (4) ◽  
pp. 742-751 ◽  
Author(s):  
Simon R Knowles ◽  
Lesley A Graff ◽  
Helen Wilding ◽  
Catherine Hewitt ◽  
Laurie Keefer ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Inflammatory Bowel ◽  
Meta Analyses

scholarly journals Systematic Review of Health-related Quality of Life Measures for Inflammatory Bowel Disease

2015 ◽  
Vol 9 (3) ◽  
pp. 284-292 ◽  
Author(s):  
Laith Alrubaiy ◽  
Ibtihal Rikaby ◽  
Phedra Dodds ◽  
Hayley Anne Hutchings ◽  
John Gordon Williams
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Health Related Quality ◽  
Quality Of Life Measures ◽  
Related Quality ◽  
Health Related ◽  
Inflammatory Bowel

scholarly journals A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review

Pharmacy ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 204
Author(s):  
Sharmila S. Prasad ◽  
Kerith Duncanson ◽  
Simon Keely ◽  
Nicholas J. Talley ◽  
Therése Kairuz ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Primary Care ◽  
Inflammatory Bowel Disease ◽  
Chronic Disease ◽  
Bowel Disease ◽  
Inflammatory Bowel

Background and aims: Chronic disease, particularly inflammatory bowel disease (IBD), requires a multifaceted approach to managing patients, but it is apparent that primary care pharmacists are being underutilized. To demonstrate the benefits of pharmacist interventions in primary care, a systematic review was conducted of interventions in asthma and type 2 diabetes where pharmacists have a defined role in chronic disease management. We also explored potential opportunities for primary care pharmacists to deliver tailored care to patients with inflammatory bowel disease. Methods: The search strategy retrieved original research articles from seven databases; eligible articles were assessed for inclusion. Quality appraisal was performed independently by two reviewers. Results: Thirty-seven included studies were grouped into four categories of interventions: education/counseling (43%), medication management (34%), monitoring/follow-up (17%), and screening/risk prevention (6%). Education plus counseling was reported as the main intervention delivered by pharmacists. Three measurable outcomes were identified: clinical, humanistic (e.g., quality of life), and economic. Clinical outcomes (63%) were reported more commonly than humanistic (26%) and economic (11%) outcomes. Pharmacist interventions led to statistically significant improvements in control of disease, severity, and medication adherence, as well as improvements in overall patient satisfaction, quality of life among patients with asthma and type 2 diabetes. Conclusion: As one of the most accessible sources of primary health care, pharmacists are well-placed to minimize the impact of chronic diseases on patients and communities. Evidence suggests there are opportunities for primary care pharmacists to play a more active role in the management of chronic diseases such as IBD.

scholarly journals The physiological and psychological effects of cognitive behavior therapy on patients with inflammatory bowel disease before COVID-19: a systematic review

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Jie Chen ◽  
Xuejie Chen ◽  
Yuhao Sun ◽  
Ying Xie ◽  
Xiaoyan Wang ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Disease Activity ◽  
Bowel Disease ◽  
Psychological Effects ◽  
Cochrane Library ◽  
Inflammatory Bowel ◽  
The Impact

Abstract Objective Cognitive behavioral therapy (CBT) is now included in the treatment of patients with inflammatory bowel disease (IBD) in many settings. However, different clinical trials report different outcomes without consensus. This study aims to evaluate the impact of CBT on the mental state, quality of life and disease activity of patients with IBD. Design Systematic review. Methods This systematic review searched eligible studies from 1946 to December 8, 2019, in MEDLINE, EMBASE, CINAHL, Cochrane library, ClinicalTrials.gov, PsycINFO, Web of Science for eligible randomized controlled trials (RCT). Results Among the initial identified 1807 references, 11 studies met inclusion criteria. CBT was shown to improve patient's quality of life and reduce the level of depression and anxiety post-intervention but was not sustained. Evidence is not enough for the effect of CBT on disease activity, or C-reactive protein level. Conclusions CBT has shown short-term positive psychological effects on IBD patients, but there is insufficient evidence for sustained physical and psychological improvements of IBD patients. PROSPERO registration: CRD42019152330.

scholarly journals Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses—Part II

2018 ◽  
Vol 24 (5) ◽  
pp. 966-976 ◽  
Author(s):  
Simon R Knowles ◽  
Laurie Keefer ◽  
Helen Wilding ◽  
Catherine Hewitt ◽  
Lesley A Graff ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Inflammatory Bowel ◽  
Meta Analyses
Sign in / Sign up

Export Citation Format

Share Document